SMS Lifesciences India Limited (SMSLIFE.NS)

INR 1533.0

(-0.21%)

Operating Income Summary of SMS Lifesciences India Limited

SMS Lifesciences India Limited's latest annual operating income in 2023 was 359.47 Million INR , down -10.37% from previous year.
SMS Lifesciences India Limited's latest quarterly operating income in 2024 Q1 was 126.05 Million INR , up 144.38% from previous quarter.
SMS Lifesciences India Limited reported an annual operating income of 180.47 Million INR in 2022, down -26.8% from previous year.
SMS Lifesciences India Limited reported an annual operating income of 246.53 Million INR in 2021, up 10.13% from previous year.
SMS Lifesciences India Limited reported a quarterly operating income of 55.67 Million INR for 2023 Q3, up 24.66% from previous quarter.
SMS Lifesciences India Limited reported a quarterly operating income of 44.65 Million INR for 2023 Q2, up 483.41% from previous quarter.

Annual Operating Income Chart of SMS Lifesciences India Limited (2023 - 2015)

Historical Annual Operating Income of SMS Lifesciences India Limited (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	359.47 Million INR	-10.37%
2022	180.47 Million INR	-26.8%
2021	246.53 Million INR	10.13%
2020	223.85 Million INR	27.35%
2019	175.78 Million INR	-38.25%
2018	284.65 Million INR	275.68%
2017	75.77 Million INR	-66.48%
2016	226.04 Million INR	1221963.28%
2015	-18.5 Thousand INR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	126.05 Million INR	144.38%
2023 Q3	55.67 Million INR	24.66%
2023 Q2	44.65 Million INR	483.41%
2023 Q1	-11.64 Million INR	-164.1%
2023 Q4	75.76 Million INR	36.1%
2023 FY	161.75 Million INR	-10.37%
2022 Q2	57.78 Million INR	-2.04%
2022 FY	180.47 Million INR	-26.8%
2022 Q4	18.17 Million INR	-74.87%
2022 Q1	58.99 Million INR	9.51%
2022 Q3	72.32 Million INR	25.15%
2021 Q4	53.87 Million INR	-7.86%
2021 Q3	58.46 Million INR	-15.53%
2021 Q1	60.78 Million INR	-10.25%
2021 FY	246.53 Million INR	10.13%
2021 Q2	69.2 Million INR	13.85%
2020 Q1	44.47 Million INR	109.18%
2020 FY	223.85 Million INR	27.35%
2020 Q4	67.73 Million INR	43.49%
2020 Q3	47.2 Million INR	-21.37%
2020 Q2	60.02 Million INR	34.96%
2019 Q2	64.73 Million INR	-18.01%
2019 FY	175.78 Million INR	-38.25%
2019 Q4	21.26 Million INR	194.95%
2019 Q3	7.2 Million INR	-88.86%
2019 Q1	78.94 Million INR	15.73%
2018 Q3	99.15 Million INR	48.76%
2018 FY	284.65 Million INR	275.68%
2018 Q4	68.21 Million INR	-31.2%
2018 Q1	50.38 Million INR	819.08%
2018 Q2	66.65 Million INR	32.3%
2017 FY	75.77 Million INR	-66.48%
2017 Q4	5.48 Million INR	-86.68%
2017 Q1	29.47 Million INR	-36.77%
2017 Q2	12.16 Million INR	-58.71%
2017 Q3	41.14 Million INR	238.14%
2016 Q1	73.89 Million INR	0.0%
2016 Q2	37.61 Million INR	-49.09%
2016 FY	226.04 Million INR	1221963.28%
2016 Q3	75.64 Million INR	101.08%
2016 Q4	46.61 Million INR	-38.37%
2015 FY	-18.5 Thousand INR	0.0%

Peer Operating Income Comparison of SMS Lifesciences India Limited

Name	Operating Income	Operating Income Difference
Biocon Limited	50.83 Billion INR	99.293%
Blue Jet Healthcare Limited	3.37 Billion INR	89.34%
Concord Biotech Limited	6.26 Billion INR	94.259%
Dishman Carbogen Amcis Limited	-413 Million INR	187.039%
Jubilant Ingrevia Limited	2.93 Billion INR	87.773%
Lyka Labs Limited	29.13 Million INR	-1134.027%
Panacea Biotec Limited	- INR	-Infinity%
Piramal Pharma Limited	4.31 Billion INR	91.669%
Supriya Lifescience Limited	1.57 Billion INR	77.128%
Syngene International Limited	6.46 Billion INR	94.442%
TAKE Solutions Limited	-213.49 Million INR	268.379%
Zota Health Care Limited	-129.79 Million INR	376.952%